Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Brunner Thomas Baptist |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Brunner, TB; Andratschke, N; Boda-Heggemann, J; Buergy, D; Corradini, S; Dieckmann, KA; Gawisch, A; GErum, S; Gkika, E; Grohmann, M; Hörner-Rieber, J; Kirste, S; Klement, RJ; Lehner, J; Moustakis, J; Nägler, F; Nestle, U; Niyazi, K-M; Rühle, A; Tanadini-Lnag, S; Wiehle, R; Winkler, P; Zurl, B; Wittig-Sauerwein, A; Blanck, O
Konsnsus Empfehlungen der DEGRO AG Radiochirurgie und Stereotaktische Strahlentherapie zur SBRT-Dosisverschreibung gemäß dem ICRU-Report 91
DEGRO 2024 Abstractband; Strahlenther Onkol.. 2024; 200(Suppl1):S89-S89.-Kongress der Deutschen Gesellschaft für Radioonkologie – DEGRO 2024; JUN 13-15, 2024; Kassel, GERMANY.
[Poster]
Brunner, TB; Boda-Heggemann, J; Buergy, D; Corradini, S; Dieckmann, UK; Gerum, S; Gkika, E; Hoerner-Rieber, J; Kirste, S; Klement, R; Moustakis, C; Niyazi, M; Ruehle, A; Tanadini-Lang, S; Winkler, P; Zurl, B; Blanck, O
General and Organ Specific Consensus Recommendations for Stereotactic Body Radiotherapy Dose Prescription according to ICRU Report 91 from Working Groups on Stereotactic Radiotherapy
INT J RADIAT ONCOL. 2024; 120(2):S219-S220.-66th ASTRO International Conference; SEP 29-OCT 2, 2024; Washington, USA.
[Oral Communication]
Web of Science
Brunner, TB; Lordick, F; Schmoor, C; Schmidberger, H; Kirste, S; Rieken, S; Petersen, C; Nicolay, NH; Fokas, E; Dunst, J; Rades, D; Eble, MJ; Krause, M; Roedel, C; Medenwald, D; Niehoff, P; Wittig-Sauerwein, A; Baues, C; Grosu, A; Hoeppner, J
Neoadjuvant Chemoradiation (CROSS) vs. Perioperative Chemotherapy (FLOT) in Esophageal Adenocarcinoma (EAC): ESOPEC - a Randomised Controlled Prospective Multicentre Phase Ill Trial
INT J RADIAT ONCOL. 2024; 120(2): S6-S6.
[Poster]
Web of Science
Lehner, J; Gawish, A; Medenwald, D; Walke, M; Konrad, T; Zurl, B; Winkler, P; Brunner, TB
Multiparametrische Dosisverschreibung einer primären SBRT bei voluminösen linkslateralen intrahepatischen cholangiozellulären Karzinomen nahe kritischer Risikoorgane
DEGRO 2024 Abstractband; Strahlenther Onkol. 2024; 200(Suppl1):S153-S153.-Kongress der Deutschen Gesellschaft für Radioonkologie – DEGRO 2024; JUN 13-15, 2024; Kassel, GERMANY.
[Poster]
Moustakis, C; Blanck, O; Grohmann, M; Albers,D; Bartels, D; Bathen, B; Borzi, GR; Broggi, S; Bruschi, A; Casale, M; Delana, A; Doolan, P; Tazehmahalleh FE; Fabiani S; Falco, MD; Fehr, R; Friedlein M; Gutser, S; Hamada, A; Hancock, T; Köhn, J; Kornhuber, C; Krieger, T; Lambrecht, U; Lappi, S; Moretti, E; Mirus, A; Müdder, T; Plaude, S; Polivka, B; Ravaglia, V; Righetto, R; Rinaldin G; Schachner, H; Scaggion, A; Schilling, P; Szeverinski, P; Villagi, E; Walke, M; Wilke, L; Winkler, P; Nicolay, NH; Eich, HT; Gkika, E; Brunner, TB, Schmitt, D
Planungs-Benchmark-Studie zur stereotaktischen Strahlentherapie von Pankreaskarzinomen mit simultan integriertem Boost und Protektion: Ergebnisse der DGMP-AK/DEGRO-AG Radiochirurgie und Stereotaxie
DEGRO 2024 Abstractband; Strahlenther Onkol. 2024; 200(Suppl ):S37-S38.-30. Kongress der Deutschen Gesellschaft für Radioonkologie – DEGRO 2024; JUN 13 - 15, 2024; Kassel, GERMANY.
[Oral Communication]
Radicioni, G; Spohn, SKB; Eichhorst, A; R hle, A; Hartong, N; Popp, I; Adebahr, S; Brunner, TB; Grosu, AL; Gkika, E
Local control and toxicity after upper abdominal SBRT with Simultaneous Integrated Protection (SIP)
RADIOTHER ONCOL. 2024; 194: S2249-S2250.
[Poster]
Web of Science
Seiß, L; Löcsei, Z; Winkler, P; Stranzl-Lawatsch, H; Brunner, TB
Digitale Schnittbildanatomie und -tumorpathologie in CT, MR PET als innovatives Lehrmodul
DEGRO 2024 Abstractband; Strahlenther Onkol. 2024; 200(Suppl1):S107-S108.-Kongress der Deutschen Gesellschaft für Radioonkologie – DEGRO 2024; JUN 13-15, 2024; Kassel, GERMANY.
[Poster]
Seiss, L; Locsei, Z; Winkler, P; Stranzl-Lawatsch, H; Brunner, TB
Radiation Oncology Hands-on Undergraduate Teaching: Digital Cross Sectional Anatomy and Tumor Pathology in CT, MRI and PET
INT J RADIAT ONCOL. 2024; 120(2):E677-E677.-66th ASTRO International Conference; SEP 29-OCT 2, 2024; Washington, USA.
[Poster]
Web of Science
Brunner, T; Langsenlehner, T; Stranzl-Lawatsch, H; Winkler, P
Rise of irradiated patients with prostate cancer and no other tumours during the corona pandemy
RADIOTHER ONCOL. 2023; 182: S876-S877.-Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO); MAY 12-16, 2023; Vienna, AUSTRIA.
[Poster]
Web of Science
Buchner, JA; Kofler, F; Mayinger, MC; Brunner, TB; Wittig, A; Menze, B; Zimmer, C; Meyer, B; Guckenberger, M; Andratschke, N; ElShafie, R; Rogers, S; Schulze, K; Blanck, O; Zamboglou, C; Grosu, A; Combs, SE; Bernhardt, D; Wiestler, B; Peeken, JC
What MRI Sequences are Necessary for Automated Neural Network-Based Metastasis Segmentation An Ablation Study
INT J RADIAT ONCOL. 2023; 117(2): E704-E705.
[Poster]
Web of Science
PubMed
Kostyszyn, D; Sachpazidis, I; Thomann, B; Gawron, M; Radicioni, G; Brunner, T; Grosu, AL; Gkika, E; Baltas, D
Prescription-free, radiobiology-based inverse radiation planning
STRAHLENTHER ONKOL. 2023; 199: S46-S46.
[Poster]
Web of Science
Locsei, Z; Nagy, B; Brunner, T; Mangel, L
Effect of radiotherapy in deep inspiration in patients with left breast cancer: Does the size of the target area affect the dose for the most crucial organs at risk?
ANN ONCOL. 2023; 34: S315-S315.
Doi: 10.1016/j.annonc.2023.09.526
[Poster]
Web of Science
FullText
FullText_MUG
Paal, K ; Stranz, B; Thurner, EM; Brunner, TB; Langsenlehner T
Blutbildveränderungen im Rahmen der definitiven Radiotherapie des Prostatakarzinoms
https://www.oegro-jahrestagung.at/wp-content/uploads/2023/10/OeGRO-Programm-2023_1010.pdf. 2023; -40. Jahrestagung der ÖGRO; 13.-14.10.2023; Vienna, Austria.
[Poster]
Paal, K; Stranz, B; Hassler, E; Magyar, M; Brunner, TB; Langsenlehner, T; Partl, R
Prognostic Significance of Platelet-Leukocyte Ratio in Patients undergoing neoadjuvant radiochemotherapy for Rectal Cancer
STRAHLENTHER ONKOL. Abstracts. 2023; 199(S1):S74-S74.-29th Annual Congress of the DEGRO; JUN 22-24, 2023; Kassel, GERMANY.
[Poster]
Web of Science
Paal, K; Stranz, B; Thurner, EM; Brunner, TB; Langsenlehner, T;
Association between age-associated Biomarkers and radiogenic Acute Toxicity in Prostate Cancer Patients
STRAHLENTHER ONKOL. Abstracts. 2023; 199(S1):S12-S12.-29th Annual Congress of the DEGRO; JUN 22-24, 2023; Kassel, GERMANY.
[Oral Communication]
Web of Science
Paal, K; Stranz, B; Thurner, EM; Brunner, TB; Langsenlehner T
Einfluss der Radiotherapie auf Veränderungen von Alterungsassoziierten Biomarkern
https://www.oegro-jahrestagung.at/wp-content/uploads/2023/10/OeGRO-Programm-2023_1010.pdf. 2023; -40. Jahrestagung 2023 der ÖGRO; 13.-14.10.2023; Vienna, Austria.
[Oral Communication]
Santic, J; Paal, K; Stranzl-Lawatsch, H; Langsenlehner, T; Winkler, P; Brunner, T
COVID-19 and its Consequences: Isolated Increase in Patients treated with Radiation Oncology only for Prostate Cancer during the Pandemic
STRAHLENTHER ONKOL. Abstracts. 2023; 199(S1):S149-S149.-29th Annual Congress of the DEGRO; JUN 22-24, 2023; Kassel, GERMANY.
[Poster]
Web of Science
Tamaskovics, BF; Hecht, M; Schubert, P; Kallies, A; Illmer, T; Radke, J; Koelbl, O; Steger, F; Brunner, TB; Rödel, C; Fleischmann, M; Reinacher-Schick, A; Wingender, LF; Melchior, P; Klautke, G; Hintzen, U; Gaipl, US; Haussmann, J; Budach, W; Fietkau, R
Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial
ANN ONCOL. 2023; 34: S593-S593.
Doi: 10.1016/j.annonc.2023.09.2088
[Poster]
Web of Science
FullText
FullText_MUG
Hass, P; Brunner, TB; Gawish, A; Ott, D
ALBI & IBI score could help in deciding for or against a radioablative therapy in patients with HCC
RADIOTHER ONCOL. 2021; 161: S1015-S1016.
Web of Science
Hass, P; Walke, M; Gawish, A; Brunner, TB
Is local ablative radiotherapy for liver malignancies an alternative to surgical resection?
RADIOTHER ONCOL. 2021; 161: S1202-S1203.
Web of Science
Brunner, TB; Bettinger, D; Schultheiss, M; Maruschke, L; Bartl, N; Kirste, S; Bamberg, F; Thimme, R; Grosu, A; Gkika, E
Stereotactic Body Radiotherapy vs Transarterial Chemoembolization In Locally Advanced Hepatocellular Carcinoma (HERACLES: Hepatocellular Carcinoma Stereotactic Radiotherapy Clinical Efficacy Study)
INT J RADIAT ONCOL. 2020; 108(3): E574-E574.
Web of Science
Gkika, E; Moustakis, C; Fechter, T; Ernst, F; Saria-Vargas, G; Dieckmann, K; Dobiasch, S; Duma, MN; Eberle, F; Gerum, S; Haussler, B; Izaguirre, V; Jazmati, D; Lautenschlager, S; Lohaus, F; Mantel, F; Menzel, J; Pachmann, S; Pavic, M; Radlanski, K; Riesterer, O; Roder, F; Trog, D; Willner, J; Blanck, O; Brunner, TB
Inter-observer Variability in the Target Volume Definition for stereotactic Radiation Therapy of Pancreatic Cancer. A Study by DEGRO AG Stereotaxy
STRAHLENTHER ONKOL. 2020; 196(SUPPL 1): S98-S99.
Web of Science
Gomez, J; Castano, F; Castilla, L; Corral, S; Acosta, J; Araguas, P; Torres, L; Arquez, M; Arguis, M; Gomez, D; Lopez, Y; Murcia, M; Gomez, E; Aparicio, C; Atanassoff, A; Blanco, J; Tomas, ER; Brunner, TB; Pazos, M; Arenas, M
Reirradiation in Breast Cancer: Clinical Outcome and Dosimetric Aspects of a Retrospective Study
INT J RADIAT ONCOL. 2020; 108(3): E68-E68.
Web of Science
Grosser, OS; Walke, M; Abdullayev, N; Andrae, K; Wordehoff, H; Kreissl, MC; Brunner, TB
Assessment of the Risk of Liver Toxicity of liver SBRT after Selective internal Radiotherapy (SIRT)
STRAHLENTHER ONKOL. 2020; 196(SUPPL 1): S102-S102.
Web of Science
Hass, P; Walke, M; Wordehoff, H; Brunner, TB; Mohnike, K
Is a local ablative Radiotherapy, e.g. in Form of an interstitial HDR-Brachytherapy of primary or secondary Liver Malignancies an Alternative to Surgical Resection?
STRAHLENTHER ONKOL. 2020; 196(SUPPL 1): S100-S100.
Web of Science
Ochel, HJ; Gabriel, C; Waldleben, AM; Wolleschak, D; Gademann, G; Fischer, T; Walke, M; Brunner, TB; Heinicke, T
Allogeneic Stem Cell Transplantation after Whole Body Irradiation with helical Tomotherapy
STRAHLENTHER ONKOL. 2020; 196(SUPPL 1): S56-S56.
Web of Science
Ott, D; Brunner, TB; Hass, P
Can alternative Liver Function Scores facilitate the Indication for radioablative Therapy in Patients with hepatocellular Carcinoma?
STRAHLENTHER ONKOL. 2020; 196(SUPPL 1): S88-S89.
Web of Science
Adebahr, S; Wagner, K; Brunner, TB; Gkika, E; Rischke, HC; Grosu, A; Vach, W; Nestle, U
Evaluation of High-Risk Imaging Features for Detection of Local Progression after Stereotactic Body Radiotherapy (SBRT) of Malignant Pulmonary Lesions in the prospective STRIPE -trial
INT J RADIAT ONCOL. 2019; 105(1): S145-S145.
Doi: 10.1016/j.ijrobp.2019.06.144
Web of Science
FullText
FullText_MUG
Bartl, N; Adebahr, S; Kirste, S; Popp, I; Schafer, H; Grosu, A; Brunner, TB; Gkika, E
The role of FDG PET / CT in SBRT of primary tumors in the upper abdomen
RADIOTHER ONCOL. 2019; 133: S781-S782.
Web of Science
Bartl, N; Adebahr, S; Kirste, S; Popp, I; Schafer, H; Grosu, A; Brunner, TBB; Gkika, E
The prognostic significance of neutrophil / lymphocyte ratio for SBRT of cholangiocellular carcinoma
RADIOTHER ONCOL. 2019; 133: S781-S781.
Web of Science
Brunner, TB; Bettinger, D; Schultheiss, M; Maruschke, L; Bartl, N; Kirste, S; Bamberg, F; Ihorst, G; Thimme, R; Grosu, A; Gkika, E
The Role of Stereotactic Body Radiotherapy (SBRT) in Locally Advanced Hepatocellular Carcinoma Versus Transarterial Chemoembolization (TACE): A Prospective, Non-Randomized Observational Trial (HERACLES)
INT J RADIAT ONCOL. 2019; 105(1): E214-E214.
Doi: 10.1016/j.ijrobp.2019.06.2058
Web of Science
FullText
FullText_MUG
Gkika, E; Bettinger, D; Schultheiss, M; Maruschke, L; Bartl, N; Kirste, S; Bamberg, F; Thimme, R; Grosu, AL; Brunner, TB
The Role of stereotactic Radiotherapy (SBRT) in locally advanced hepatocellular Carcinoma compared with transarterial Chemoembolization (TACE). A prospective, non-randomized Observational Study (Heracles Study)
STRAHLENTHER ONKOL. 2019; 195: S7-S7.
Web of Science
Gkika, E; Nugues, L; Weis, C; Bartl, N; Kirste, S; Adebahr, S; Wiehle, R; Baltas, D; Brunner, TB; Grosu, AL
Central hepatobiliary Toxicity in hypofractionated and stereotactic Radiotherapy of the Liver. Do we need Constraints?
STRAHLENTHER ONKOL. 2019; 195: S70-S70.
Web of Science
Gkika, E; Poujol, M; Bartl, N; Wiehle, R; Baltas, D; Kirste, S; Adebahr, S; Grosu, AL; Brunner, TB
Evaluation of gastrointestinal Dose Limits in stereotactic and hypofractionated Radiotherapy of the Abdomen. What is "safe"?
STRAHLENTHER ONKOL. 2019; 195: S38-S38.
Web of Science
Grosu, A; Ckika, E; Brunner, T; Strouthos, J; Weinberg, U
Phase 2 HEPANOVA trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma
ANN ONCOL. 2019; 30:
Web of Science
Hass, P; Brunner, TB; Walke, M; Albers, D; Gauer, T; Petersen, C; Walter, F; Ricke, J; Corradini, S
Local Radio Ablation in Liver Malignancies: Which Method is better? ESPRIT Study: A dosimetric Comparison of interstitial HDR Brachytherapy (iBT) and Body Stereotactic (SBRT)
STRAHLENTHER ONKOL. 2019; 195: S103-S103.
Web of Science
Hass, P; Drews, R; Omari, J; Othmer, M; Pech, M; Powerski, M; Brunner, TB
CT-assisted local ablative interstitial HDR Brachytherapy of hepatic, pancreatic or LK Oligometastases in metastatic Gastric Adenocarcinoma as Second-line or Salvage Therapy
STRAHLENTHER ONKOL. 2019; 195: S101-S101.
Web of Science
Hass, P; Meyer, F; Costa, SD; Liehr, U; Perrakis, A; Croner, RS; Brunner, TB
Locally advanced Cervical Carcinoma with extensive vaginal Fistula: Case Description of 2 individual trimodal Treatment Concepts
STRAHLENTHER ONKOL. 2019; 195: S101-S101.
Web of Science
Hass, P; Walke, M; Willich, C; Braun-Dullaeus, RC; Dittrich, I; Brunner, TB
Personalized Radioimmunotherapy as a Re-treatment of extensive right ventricular Metastasis of NSCLC (non-small cell Lung Carcinoma)
STRAHLENTHER ONKOL. 2019; 195: S94-S95.
Web of Science
Hofheinz, R; Fokas, E; Allgauer, M; Polat, B; Klautke, G; Grabenbauer, G; Fietkau, R; Kuhnt, T; Staib, L; Brunner, T; Grosu, A; Schmiegel, W; Jacobasch, L; Weitz, J; Folprecht, G; Germer, C; Grutzmann, R; Schwarzbach, M; Bechstein, W; Friede, T; Ghadimi, M; Rodel, C
Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12
ANN ONCOL. 2019; 30:
Web of Science
Gkika, E; Bettinger, D; Krafft, L; Schultheiss, M; Neeff, HP; Schulenburg, M; Adebahr, S; Kirste, S; Nestle, U; Thimme, R; Grosu, AL; Brunner, TB
The Role of different prognostic Scores in the hepatocellular Carcinoma Therapy
STRAHLENTHER ONKOL. 2017; 193: S57-S57.
Web of Science
Gkika, E; Hallauer, L; Kirste, S; Adebahr, S; Bartl, N; Neeff, HP; Fritsch, R; Brass, V; Nestla, U; Grosu, AL; Brunner, TB
The Stereotactic Radiotherapy for treating Patients with locally advanced Cholangiocarcinoma
STRAHLENTHER ONKOL. 2017; 193: S44-S45.
Web of Science
Gkika, E; Kirste, S; Adebahr, S; Neeff, HP; Schultheiss, M; Nestle, U; Grosu, AL; Brunner, TB
Liver Re-Irradiation of Patients with recurrent primary and secondary Liver Cancer, using SBRT. A Toxicity Analysis
STRAHLENTHER ONKOL. 2017; 193: S57-S57.
Web of Science
Brunner, TB; Ernst, I; Blanck, O; Andratschke, N; Lewitzki, V; Ganswindt, U; Wachter, S; Alheit, H; Gkika, E; Guckenberger, M
Stereotactic body radiotherapy in hepatocellular and cholangiocellular carcinoma (HCC, CCC): First results of the German Society of Radiation Oncology (DEGRO) working group "stereotactic therapy" cohort.
ONCOL RES TREAT. 2016; 39: 165-166.
Web of Science
Brunner, TB; Ernst, I; Blanck, O; Andratschke, N; Liwitzki, V; Ganswindt, U; Wachter, S; Alheid, H; Gkika, E; Guckenberger, M
Stereotactic body radiotherapy in hepatocellular and cholangiocellular carcinoma (HCC, CCC): First results of the German Society of Radiation Oncology (DEGRO) working group "stereotactic therapy" cohort
STRAHLENTHER ONKOL. 2016; 192: 25-26.
Web of Science
Schnell, D; Grosu, AL; Brunner, TB
Long-term Survival through aggressive Therapeutic Strategies in Patients with anaplastic Thyroid Cancer and metachronous Metastasis - A Case Report
STRAHLENTHER ONKOL. 2016; 192: 70-70.
Web of Science
Zipfel, AS; Grosu, AL; Brunner, TB
SBRT (stereotactic body radiation therapy) for treating Patients with primary inoperable malignant perivascular epithelioid cell Tumor (PEComa) of the Liver and followed by the Resection - A Case Report
STRAHLENTHER ONKOL. 2016; 192: 139-140.
Web of Science
Brunner, TB; Wiehle, R; Kirste, S; Rohner, F; Prokic, V; Grosu, AL; Nestle, U
SIB-SIP: Combined simultaneous integrated boost and protection for upper abdominal SBRT
RADIOTHER ONCOL. 2015; 115: S388-S389.
Web of Science
Thomsen, AR; Aldrian, C; Melin, N; Heselich, A; Niedermann, G; Brunner, TB
Stromal Cells as supportive and as inhibiting Factor-3D-Cultures with Pancreatic Cancer Cells
STRAHLENTHER ONKOL. 2015; 191: S78-S78.
Web of Science
Wilson, JM; Mukherjee, S; Brunner, TB; Partridge, M; Hawkins, MA
The Application of Pre and Post Chemoradiation Therapy FDG-PET/CT to Treatment Strategy Selection in Locally Advanced Pancreatic Cancer
INT J RADIAT ONCOL. 2015; 93(3): E130-E131.
Doi: 10.1016/j.ijrobp.2015.07.880
Web of Science
FullText
FullText_MUG
Wilson, JM; Mukherjee, S; Grimes, DR; Durrant, L; Brunner, TB; Partridge, M; Hawkins, MA
Fluoromisonidazole-PET/CT in pancreatic cancer: moving towards hypoxic biological target volume definition
RADIOTHER ONCOL. 2015; 115: S343-S344.
Web of Science
Aldrian, C; Melin, N; Zamboglou, C; Nanko, N; Niedermann, G; Brunner, TB; Thomsen, AR
Agarose-based Ko-Kultures of Tumor- and Stromal Cells - a 3D-Model for Tadiation Biology
STRAHLENTHER ONKOL. 2014; 190: 81-81.
Web of Science
Bittner, MI; Grosu, AL; Brunner, TB
Comparison of the toxicity of t versus three-dimensional conformal radiotherapy intnsity tsmodulierter in pancreatic cancer
STRAHLENTHER ONKOL. 2014; 190: 33-34.
Web of Science
Bittner, MI; Grosu, AL; Brunner, TB
Pancreatic cancer: Comparison of toxicity of IMRT and 3D-conformal radiotherapy (3D-CRT)
RADIOTHER ONCOL. 2014; 111: S115-S115.
Web of Science
Brunner, TB; Grosu, AL; Nestle, U; Partridge, M
Stereotactic body radiotherapy (SBRT) in pancreatic cancer: What is the therapeutic window?
STRAHLENTHER ONKOL. 2014; 190: 11-11.
Web of Science
Brunner, TB; Kirste, S; Nestle, U; Grosu, AL; Wiehle, R
SIP (Simultaneous Integrated Protection Volume)-Concept for the SBRT in Patients with Pancreatic Carcinoma
STRAHLENTHER ONKOL. 2014; 190: 122-122.
Web of Science
Brunner, TB; Kirste, S; Schultheiss, M; Euringer, W; Neeff, H; Schulenburg, M; Thimme, R; Grosu, AL
Stereotactical Radiotherapy in the Hepatocellular Carcinoma (HCC). A single-center Phase II Study
STRAHLENTHER ONKOL. 2014; 190: 10-11.
Web of Science
Brunner, TB; Nestle, U; Grosu, AL; Partridge, M
Stereotactic body radiotherapy (SBRT) in pancreatic cancer: What is the therapeutic window?
RADIOTHER ONCOL. 2014; 111: S100-S100.
Web of Science
Brunner, TB; Wilson, J; Mukherjee, S; Chu, KY; Partridge, M; Hawkins, M
Approaches for Use of the 18 F-Fluorodeoxyglucose-PET CT to Define a biological Boost Volume in locally advanced Pancreatic Carcinoma
STRAHLENTHER ONKOL. 2014; 190: 91-91.
Web of Science
Chu, K; Eccles, CL; Warren, S; Brunner, TB; Mukherjee, S; Hawkins, M
Impact of Weight Change on Dose Delivery in Pancreatic Intensity Modulated Radiation Therapy
INT J RADIAT ONCOL. 2014; 90: S862-S863.
Doi: 10.1016/j.ijrobp.2014.05.2466
Web of Science
FullText
FullText_MUG
Kirste, S; Trautsch, H; Messmer, B; Grosu, AL; Momm, F; Brunner, TB
Upper abdominal stereotactic radiotherapy (SBRT): Correlation of local control with biological equivalent dose
RADIOTHER ONCOL. 2014; 111: S117-S117.
Web of Science
Lunardi, S; Jamieson, NB; Griffiths, KL; Carvalho-Gaspar, MM; Lim, SY; Al-Assar, O; Carter, RC; Mckay, CJ; Silva, MA; Janssen, KP; Muschel, RJ; Brunner, TB
IP-10/CXCL10 expression is induced in tumor stroma in pancreatic cancer and correlates with poor survival in patients
STRAHLENTHER ONKOL. 2014; 190: 77-77.
Web of Science
Thomsen, AR; Aldrian, C; Melin, N; Heselich, A; Barent, C; Wiedenmann, N; Rucker, G; Niedermann, G; Brunner, TB
Klonogenes Survival: A simplified Limiting Dilution Method as an Alternative to classical Colony forming-Assays
STRAHLENTHER ONKOL. 2014; 190: 83-83.
Web of Science
Wilson, JM; Mukherjee, S; Chu, KY; Brunner, TB; Partridge, M; Hawkins, MA
Biological target volume definition in locally advanced pancreatic cancer: how useful is FDG-PET?
RADIOTHER ONCOL. 2014; 111: S26-S26.
Web of Science
Brunner, TB; Golcher, H; Witzigmann, H; Marti, L; Bechstein, WO; Bruns, C; Jungnickel, H; Schreiber, S; Grabenbauer, GG; Meyer, T; Merkel, S; Fietkau, R; Hohenberger, W
Preoperative chemoradiation for resectable adenocarcinoma of pancreatic head: results of a randomized phase-II trial
STRAHLENTHER ONKOL. 2013; 189: 18-18.
Web of Science
Fokas, E; Eccles, CE; Patel, N; Chu, KY; Warren, S; McKenna, WG; Brunner, TB
A comprehensive dosimetric comparison of four target volume definitions for pancreatic cancer and their influence on lymphatics and organs at risk
STRAHLENTHER ONKOL. 2013; 189: 96-96.
Web of Science
Fokas, E; Prevo, R; Pollard, JR; Reaper, PM; Charlton, P; Cornelissen, B; Vallis, K; Hammond, EM; Olcina, MM; McKenna, WG; Muschel, RJ; Brunner, TB
ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
STRAHLENTHER ONKOL. 2013; 189: 41-41.
Web of Science
Schanne, DH; Kuchler, S; Henke, M; Rischke, HC; Grosu, AL; Brunner, TB
Comparison of two contouring techniques for small bowel delineation in rectal and anal cancer
STRAHLENTHER ONKOL. 2013; 189: 94-94.
Web of Science
Brunner, TB; Hill, E; Wilson, J; Maughan, T; Eccles, C; McKenna, WG
NELFINAVIR AND RT IN PANCREATIC CANCER
RADIOTHER ONCOL. 2012; 104: 29-29.
Doi: 10.1016/S0167-8140(15)34582-5
Web of Science
FullText
FullText_MUG
Al-Assar, O; Mantoni, TS; Lunardi, S; Kingham, G; Helleday, T; Brunner, TB
Breast cancer stem-like cells show enhanced homologous recombination due to a larger S-G2 fraction
STRAHLENTHER ONKOL. 2011; 187: 54-54.
Web of Science
Eccles, CL; Vallis, KA; Brunner, TB; McKenna, WG
Comparison of Locally Advanced Pancreatic Cancer Target Definition Methods on 18FDG-PET images for Radiotherapy Treatment Planning
INT J RADIAT ONCOL. 2011; 81(2): S732-S732.
Doi: 10.1016/j.ijrobp.2011.06.1305
Web of Science
FullText
FullText_MUG
Eccles, CL; Vallis, KA; McKenna, WG; Brunner, TB
A Comparison of contrast-reinforced lever Computed tomography (CECT) with FDG-PET-based Target volume definition in locally advanced Pancreatic Cancer (LAPC) for conventional and adaptive Radiochemotherapy (RCT)
STRAHLENTHER ONKOL. 2011; 187: 39-39.
Web of Science
Eccles, CL; Vallis, KA; McKenna, WG; Brunner, TB
Potential advantages and tradeoffs of intensity modulated radiotherapy for locally advanced pancreas cancer (including elective nodal volumes)
STRAHLENTHER ONKOL. 2011; 187: 39-39.
Web of Science
Mantoni, TS; Lunardi, S; McKenna, WG; Brunner, TB
The Interaction of pancreatic Cancer and Stellate Cells as a Mediator of Radiation Resistance in ductal Pancreatic Adenocarcinoma
STRAHLENTHER ONKOL. 2011; 187: 38-39.
Web of Science
Lunardi, S; Mantoni, T; Al-Assar, O; Brunner, TB
Pancreatic stellate cells modify tumour growth and radioresponse of pancreatic cancer
EJC SUPPL. 2010; 8(5): 211-211.
Doi: 10.1016/S1359-6349(10)71631-1
Web of Science
FullText
FullText_MUG
Brunner, TB; Al-Assar, O; Muschel, RJ; Mantoni, TS; McKenna, WG
The Radiation Response of Cancer Stem Cell-like Subpopulations from Established Human Cell Lines
INT J RADIAT ONCOL. 2009; 75(3): S19-S19.
Doi: 10.1016/j.ijrobp.2009.07.066
Web of Science
FullText
FullText_MUG
Brunner, TB; Al-Assar, O; Muschel, RJ; Mantoni, TS; McKenna, WG
Die hard? Radiation sensitivity of cancer stem cells from established human cell lines
EJC SUPPL. 2009; 7(2): 153-153.
Doi: 10.1016/S1359-6349(09)70521-X
Web of Science
FullText
FullText_MUG
Brunner, TB; Geiger, M; Grabenbauer, GG; Mantoni, TS; Cavallaro, A; Sauer, R; Hohenberger, W; McKenna, WG
A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
J CLIN ONCOL. 2008; 26(15):
Doi: 10.1200/jco.2008.26.15_suppl.4632
Web of Science
FullText
FullText_MUG
Cordes, N; Frick, S; Hehlgans, S; Brunner, TB; Pilarsky, C; Grutzmann, R; Bence, SBS; Kloppel, G; McKenna, WG; Bernhard, EJ
Knockdown of the integral membrane protein caveolin-1 sensitizes human pancreatic carcinoma cells to ionizing radiation
ONKOLOGIE. 2008; 31: 173-174.
Web of Science
Brunner, TB; Meier, I; Hermanek, P; Hohenberger, W; Sauer, R; Merkel, S
Adenocarcinoma of the esophagogastric (AEG) junction: Elective lymphatic target volume definition based on the pattern of metastatic lymph node dissemination
INT J RADIAT ONCOL. 2006; 66(3): S263-S263.
Doi: 10.1016/j.ijrobp.2006.07.500
Web of Science
FullText
FullText_MUG